Atlas Trials

A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients

Clinical trial NCT01313780 · COMPLETED

Trial details

NCT number
NCT01313780
Sponsor
Mundipharma Korea Ltd
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cancer
Start date
2011-05-01
Primary completion
2013-10-01
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.